A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Eluxadoline | CAS 864821-90-9 - Request Quote

Picture of Eluxadoline
SZ CAT No:SZ-E088001
CAS No
864821-90-9
Mol.F.
C32H35N5O5
Mol.Wt.
569.7
Inv. Status
In Stock
Shipping Condition Room Temperature

Chemical Name :

Shipping Temperature :

HSN Code :

Country of Origin :

Smiles :

Usage Note:

Eluxadoline is chemically 5-(((S)-2-Amino-3-(4-carbamoyl-2,6-dimethylphenyl)-N-((S)-1-(5-phenyl-1H-imidazol-2-yl)ethyl)propanamido)methyl)-2-methoxybenzoic acid. Eluxadoline is supplied with detailed characterization data compliant with regulatory guideline. Eluxadoline can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Eluxadoline.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.

Applications & Regulatory Use Cases

Buy 864821-90-9

Purchase 864821-90-9

Order 864821-90-9

Enquire 864821-90-9

price of 864821-90-9

864821-90-9 Supplier

864821-90-9 Manufacturer

864821-90-9 Exporter

buy high quality Eluxadoline

Purchase Eluxadoline

Eluxadoline suppliers

Eluxadoline manufacturers

Eluxadoline price

Order Eluxadoline

Enquire Eluxadoline

Eluxadoline cost

Eluxadoline Supplier

Eluxadoline Distributor

Eluxadoline for Method Validation

Eluxadoline Reference Standard

Eluxadoline for ANDA Filing

Eluxadoline for Forced Degradation Studies

Eluxadoline Identification Standards

Eluxadoline for DMF Filing

ℹ️

Disclaimer

SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.

SynZeal will update these details as per new developments or findings in product specifications without further notice.

,